retatrutide developer company Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide (RETA-40) 107mg Research Peptide

Liver fat content decreased by 44% in a subset of participants who underwent MRI imaging

That glucagon-related peptide is very similar to what we think of as GLP-1

Our approach is designed to support your bodys natural balance, empowering you to achieve lasting, sustainable results

FDA's concerns with unapproved GLP-1 drugs used for weight loss

Studies need to be done to better understand the changes of muscle after weight loss while on these new highly effective obesity medications. Advertisement Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more